PGI8 An Exploratory Analysis of the Survival Benefits in Commercially Insured Patients with Hepatic Encephalopathy (HE) Treated with Rifaximin versus Lactulose Alone using US Claims Data
Saved in:
| Published in | Value in health Vol. 24; pp. S95 - S96 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Inc
01.06.2021
|
| Online Access | Get full text |
Cover
Loading…
| Author | Guerin, A. Volk, M.L. Ahmad, M. Heimanson, Z. Shi, S. Joseph, G. Burne, R. |
|---|---|
| Author_xml | – sequence: 1 givenname: R. surname: Burne fullname: Burne, R. organization: Analysis Group, Inc., Montreal, QC, Canada – sequence: 2 givenname: M.L. surname: Volk fullname: Volk, M.L. organization: Loma Linda University Medical Center, Loma Linda, CA, USA – sequence: 3 givenname: A. surname: Guerin fullname: Guerin, A. organization: Analysis Group, Inc., Montreal, QC, Canada – sequence: 4 givenname: S. surname: Shi fullname: Shi, S. organization: Analysis Group, Inc., Montreal, QC, Canada – sequence: 5 givenname: G. surname: Joseph fullname: Joseph, G. organization: Bausch Health US, LLC, Bridgewater, NJ, USA – sequence: 6 givenname: Z. surname: Heimanson fullname: Heimanson, Z. organization: Bausch Health US, LLC, Bridgewater, NJ, USA – sequence: 7 givenname: M. surname: Ahmad fullname: Ahmad, M. organization: St. Joseph’s Health, Paterson, NJ, USA |
| BookMark | eNp9kEFvEzEQhVeoSLSFP8BpjnDIMrP2hl2JS0hDEykSFW3PluuMiSOvN7J3Q_ev8etwKGdOM0-a9zTvuyouQh-4KN4TloQ0_3QoDyftyworKlGWsm1eFZdUV3ImPwtxkXdsm5lAqt8UVykdEHEuqvqy-H13u2lgEWD1fPR91EMfpyy1n5JL0FsY9gz3Yzy5nA9fObB1QwIXYNl3HUfjtPcTbEIaI-_gTg-OQz745YY9rPmYtYFVMHzca99nuZ_gw3r1ER4i6yE7_h7-cFY_uy6nnjimMcFWm2H0fWJY-NwUxuTCT3i8h6XXrktwowf9tnhttU_87t-8Lh6_rR6W69n2--1mudjODEnMpVthBFVWVjskW9cN1U9aiPpJWNu2DRGhkUSMXM2ttogsZcMWSROiJCuui-ol18Q-pchWHaPrdJwUoTrTVwd1pq_O9BVKleln05cXE-fPTo6jSiaTMbxzkc2gdr37n_0PwP6R9w |
| ContentType | Journal Article |
| Copyright | 2021 |
| Copyright_xml | – notice: 2021 |
| DBID | 6I. AAFTH AAYXX CITATION |
| DOI | 10.1016/j.jval.2021.04.498 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1524-4733 |
| EndPage | S96 |
| ExternalDocumentID | 10_1016_j_jval_2021_04_498 S1098301521007154 |
| GroupedDBID | --- --K --M .1- .3N .FO .GA .Y3 .~1 0R~ 10A 123 1OC 1P~ 1~. 29Q 31~ 36B 4.4 44B 457 4G. 51W 51X 52N 52P 52R 52S 52X 53G 5LA 5VS 66C 6I. 6PF 7-5 7PT 8-1 8P~ 8UM AACTN AAEDT AAEDW AAFJI AAFTH AAFWJ AAHHS AAIAV AAIKJ AAKOC AALRI AAOAW AAPFB AAQFI AAQXK AAWTL AAXUO ABBQC ABCQN ABDBF ABEML ABIVO ABJNI ABLVK ABMAC ABMMH ABMZM ABVKL ABXDB ABYKQ ACCFJ ACDAQ ACGFS ACHQT ACPRK ACRLP ACXQS ADBBV ADEZE ADFHU ADMUD AEBSH AEEZP AEKER AENEX AEQDE AEVXI AEXQZ AEYQN AFBPY AFCTW AFEBI AFKWA AFRHN AFTJW AFXIZ AFZJQ AGHFR AGTHC AGUBO AGYEJ AIEXJ AIIAU AIKHN AITUG AIWBW AJAOE AJBDE AJBFU AJOXV AJRQY AJUYK AKYCK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AOMHK ASPBG AVARZ AVWKF AXJTR AXLSJ AZFZN BAWUL BFHJK BKOJK BLXMC BNPGV BY8 CAG CO8 COF CS3 DCZOG DIK DU5 EAD EAP EBS EFJIC EFLBG EJD EMB EMK EMOBN ESX F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN GBLVA HF~ HVGLF HZI HZ~ IHE IXB IXIXF KOM LCYCR M41 MO0 N9A NCXOZ O-L O9- OAUVE OK1 OVD P-8 P-9 P2P PC. PQQKQ PRBVW Q38 QB0 R2- RIG ROL SDF SEL SES SPCBC SSB SSF SSH SSO SSZ SUPJJ SV3 T5K TEORI TUS W99 WYUIH XG1 YFH Z5R ~G- 0SF AAXKI AAYXX ADVLN AFJKZ AKRWK CITATION OIG |
| ID | FETCH-LOGICAL-c1408-393c312f42d01f55815ba335b3ff9981110c411e0e26faf00e448ef01a10041f3 |
| IEDL.DBID | AIKHN |
| ISSN | 1098-3015 |
| IngestDate | Thu Sep 26 16:17:25 EDT 2024 Fri Feb 23 02:40:40 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | http://www.elsevier.com/open-access/userlicense/1.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c1408-393c312f42d01f55815ba335b3ff9981110c411e0e26faf00e448ef01a10041f3 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1098301521007154 |
| ParticipantIDs | crossref_primary_10_1016_j_jval_2021_04_498 elsevier_sciencedirect_doi_10_1016_j_jval_2021_04_498 |
| PublicationCentury | 2000 |
| PublicationDate | June 2021 2021-06-00 |
| PublicationDateYYYYMMDD | 2021-06-01 |
| PublicationDate_xml | – month: 06 year: 2021 text: June 2021 |
| PublicationDecade | 2020 |
| PublicationTitle | Value in health |
| PublicationYear | 2021 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| SSID | ssj0006325 |
| Score | 2.3455842 |
| SourceID | crossref elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | S95 |
| Title | PGI8 An Exploratory Analysis of the Survival Benefits in Commercially Insured Patients with Hepatic Encephalopathy (HE) Treated with Rifaximin versus Lactulose Alone using US Claims Data |
| URI | https://dx.doi.org/10.1016/j.jval.2021.04.498 |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61qYS4VFBAlEc0B1SBqMmuX_Uek5Di0IcikqDcrPXaW1y5ToUdiVz4Yfw6ZvygICEOHL3yalc7o29mdme-YezViacc7YrA8t0kwABFSku5QlkYCQgd--ji12z7F5d-uHQ_rrzVDht3tTCUVtlif4PpNVq3I4P2NAe3WTaYCy4DVE-0P2QnPXeX7aE5soMe2xtOz8LLX4DsO3XvVfrfoglt7UyT5nWNAsUw0RbEeOrK4O_26Tebc_qA7bfOIgyb_TxkO2lxwO5dtM_hB-xo1hBPb49hcVdHVR7DEczuKKm3j9iP2YdpAMMCmpS7-mUdOj4SWBtANxDmG4QN3CeMEP9MVpWQFUAFJNSUSeX5FqYF3ScmMGvIWEugW1wIU8rK1jChAsgvKl9Tl-MtvA4nb2BBPinOqH_8lBn1jbqIAeWCbEo4V7ra5OsyhWG-LlKgJPwrWM5hnKvspoT3qlKP2fJ0shiHVtu1wdIYrOEJS0c7wjaunXBhPC8QXqwcx4sdYzC2Q2zlqBwi5antG2U4T1EvUsOFIvI6YZwnrFfgmk8ZcBPHgZdIqYPENVIoiUsgQDm-PpGc60P2tpNVdNuQc0Rd1tp1RJKNSLIRdyOU7CHzOnFGf6hYhNbjH_Oe_ee85-w-fTV5ZS9Yr_q6SV-iB1PFfbb77rvoo56OPp-d91t9xdHpavQTQyzzBg |
| link.rule.ids | 315,783,787,3513,4509,24128,27581,27936,27937,45597,45675,45691,45886 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZGJwEvCAZo43oe0ARiUe0mTuPHrnSkrJ0q2qK9Wc7FkCmkE0kl-tf4dZyTCwMJ8cBrYsuWz9G52N_5DmOvhtK4sScCx_eSABMUpRzjCeNgJiDiyMcQv2bbn1_44dr7cCkv99i4q4UhWGVr-xubXlvr9ku_Pc3-dZb1l4KrANUT_Q_5SendYvsYDQxlj-2PTj-dz34ZZN-te6_SeIcmtLUzDczrCgWKaeJAEOOpp4K_-6fffM7ZfXavDRZh1OznAdtLiwN2e94-hx-w40VDPL07gdVNHVV5AsewuKGk3j1kPxbvpwGMCmggd_XLOnR8JLCxgGEgLLdoNnCfcIr2z2ZVCVkBVEBCTZlMnu9gWtB9YgKLhoy1BLrFhTAlVHYMEyqA_GLyDXU53sHrcPIGVhST4ox64MfMmu_URQwIC7ItYWbiaptvyhRG-aZIgUD4n2G9hHFusq8lvDOVecTWZ5PVOHTarg1OjMkanrByY1cMrDdIuLBSBkJGxnVl5FqLuR3aVo7KIVKeDnxrLOcp6kVquTBEXies-5j1ClzzkAG3URTIRKk4SDyrhFG4BBoo14-HivP4iL3tZKWvG3IO3aHWrjRJVpNkNfc0SvaIyU6c-g8V0-g9_jHvyX_Oe8nuhKv5TM-mF-dP2V3602DMnrFe9W2bPsdopopetNr6E--R8m8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PGI8+An+Exploratory+Analysis+of+the+Survival+Benefits+in+Commercially+Insured+Patients+with+Hepatic+Encephalopathy+%28HE%29+Treated+with+Rifaximin+versus+Lactulose+Alone+using+US+Claims+Data&rft.jtitle=Value+in+health&rft.au=Burne%2C+R.&rft.au=Volk%2C+M.L.&rft.au=Guerin%2C+A.&rft.au=Shi%2C+S.&rft.date=2021-06-01&rft.pub=Elsevier+Inc&rft.issn=1098-3015&rft.eissn=1524-4733&rft.volume=24&rft.spage=S95&rft.epage=S96&rft_id=info:doi/10.1016%2Fj.jval.2021.04.498&rft.externalDocID=S1098301521007154 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-3015&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-3015&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-3015&client=summon |